Skip to main content
SR biotek Inc. logo

SR biotek Inc. — Investor Relations & Filings

Ticker · 270210 ISIN · KR7270210008 KO Manufacturing
Open in API
Filings indexed 190 across all filing types
Latest filing 2019-12-09 Major Shareholding Noti…
Country KR South Korea
Listing KO 270210

About SR biotek Inc.

http://srbiotek.com/

SR biotek Inc. is a biotechnology and cosmeceutical company specializing in the research, development, and manufacturing of innovative skincare products. The company offers comprehensive turnkey OEM/ODM solutions to its partners, covering product development, quality control, and manufacturing. A core strength lies in the development of novel ingredients, highlighted by its proprietary bio-material, RAPHITOX, which utilizes a micro-needle shaped structure. In addition to its manufacturing services, SR biotek also develops its own branded skincare lines.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 100% confidence The document is a Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard disclosure form used in South Korea (often filed with the Financial Supervisory Service/KRX) when a major shareholder or executive changes their stake in a company. This falls under the category of 'Major Shareholding Notification' (MRQ) as it details the change in share ownership percentage (from 18.42% to 15.16%) by Core Asset Management Co., Ltd. in SR BioTech.
2019-12-09 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서). This is a standard regulatory filing in South Korea (DART system) used when a major shareholder or executive changes their stake in a company. This falls under the category of 'Major Shareholding Notification' as it details the acquisition/disposal of shares by a major shareholder (B2LINK) in the issuer (SR Biotech).
2019-11-29 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the acquisition of shares by a major shareholder (B2LINK) and related parties in SR Biotech. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided taxonomy, as it tracks changes in significant ownership levels.
2019-11-29 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by major shareholders (Song Byungho and Yoon Hong-geon) in the company SR Biotek. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) as it tracks significant ownership thresholds and changes in equity stakes.
2019-11-29 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard disclosure form used in South Korea (often filed with the Financial Supervisory Service/DART) to report insider trading or changes in shareholdings by company directors and major shareholders. Based on the provided definitions, this falls under 'Director's Dealing' (DIRS), which covers personal share transactions by company directors and executives.
2019-11-29 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서), which is a standard regulatory filing in South Korea for reporting insider transactions or changes in shareholding status by directors and major shareholders. This falls under the 'Director's Dealing' category as it details the disposal of shares by an executive/major shareholder (Yun Hong-keon) of SR Biotech.
2019-11-29 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.